Search

Displaying results 9331 - 9340 of 10000 in total
  1. Drug

    SNS-032

    go.drugbank.com/drugs/DB05969
    Investigational

  2. Drug

    MN-246

    go.drugbank.com/drugs/DB05981
    Experimental

    MN-246 is a novel ß3-adrenergic receptor agonist developed for the treatment of urinary incontinence by MediciNova Inc.

  3. Drug

    TG-C

    go.drugbank.com/drugs/DB06004
    Investigational

  4. Drug

    YKP-1358

    go.drugbank.com/drugs/DB06109
    Experimental

    In addition, the YKP1358 pharmacological profile suggests a very low potential for extrapyramidal side effects. … YKP1358 is a novel serotonin (5-HT2A) and dopamine (D2) antagonist that has demonstrated potent activity in animals that relates to both positive and negative symptoms of schizophrenia.

  5. Drug

    Amelubant

    go.drugbank.com/drugs/DB06248
    Investigational

  6. Drug

    Sulodexide

    go.drugbank.com/drugs/DB06271
    ApprovedInvestigationalWithdrawn

    Sulodexide is a mixture of glycosaminoglycans (GAGs) composed of dermatan sulfate (DS) and fast moving heparin (FMH).

  7. Drug

    Refametinib

    go.drugbank.com/drugs/DB06309
    Investigational

  8. Drug

    R-348

    go.drugbank.com/drugs/DB06321
    Investigational

  9. Drug

    Lucatumumab

    go.drugbank.com/drugs/DB06360
    Investigational

  10. Drug

    Indisulam

    go.drugbank.com/drugs/DB06370
    Investigational

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C9 Substrates